Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism
ConditionAutism
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorUniversity of Reading
About this trial
This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.
Eligibility criteria
Qualifiers
Between the ages of 18 to 60
With a diagnosis of autism
Disqualifiers
Taking any supplement that contains more than 2mg of Vitamin B6 or taking GABA agonist drugs
Have a medical history of peripheral neuropathy
lactose intolerance (placebo tablet is lactose based)
Trial design
Treatments tested in this trial
- Pyridoxal 5'-Phosphate (100 mg)
- Placebo
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Reading
Lead sponsor
INNOPURE
Collaborator
Source ClinicalTrials.gov